Therapeutic Asset Ratings
164 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Claturafenib
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(36)
Dcc-3084
Non-Small Cell Lung Carcinoma
Deciphera Pharmaceuticals, LLC
P1
C
(36)
Edb-102
Non-Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1
C
(36)
Epha2-Targeted Car-Dcs
Non-Small Cell Lung Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
C
(36)
Epha2-Targeted Car-T Cells
Non-Small Cell Lung Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
C
(36)
ft836
Non-Small Cell Lung Carcinoma
Fate Therapeutics
P1
C
(36)
Futibatinib
Non-Small Cell Lung Carcinoma
Taiho Oncology, Inc.
P1
C
(36)
FXB0871
Non-Small Cell Lung Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
P1
C
(36)
Glutathione
Non-Small Cell Lung Carcinoma
The First Affiliated Hospital of Zhengzhou University
P1
C
(36)
hs-10370
Non-Small Cell Lung Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1
C
(36)
im-1617
Non-Small Cell Lung Carcinoma
Immunome, Inc.
P1
C
(36)
imp3-sarna vaccine
Non-Small Cell Lung Carcinoma
West China Hospital
P1
C
(36)
Inavolisib
Non-Small Cell Lung Carcinoma
Genentech, Inc.
P1
C
(36)
Janx008
Non-Small Cell Lung Carcinoma
Janux Therapeutics
P1
C
(36)
kqb368
Non-Small Cell Lung Carcinoma
Kumquat Biosciences Inc.
P1
C
(36)
Kras Tcr-Transduced Pbl
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P1
C
(36)
Lncb74
Non-Small Cell Lung Carcinoma
NextCure, Inc.
P1
C
(36)
LNTH-2403
Non-Small Cell Lung Carcinoma
Radiopharm Theranostics, Ltd
P1
C
(36)
Oct-598
Non-Small Cell Lung Carcinoma
Oscotec Inc.
P1
C
(36)
Pcna Inhibitor Aoh1996
Non-Small Cell Lung Carcinoma
City of Hope Medical Center
P1
C
(36)
Pepticrad-1
Non-Small Cell Lung Carcinoma
Valo Therapeutics Oy
P1
C
(36)
pf-07329640
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(36)
pf-07799544
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(36)
pf-08046032
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(36)
PITAVASTATIN
Non-Small Cell Lung Carcinoma
Chang Chen
P1
C
(36)
Showing 126 to 150 of 164 assets
Previous
Page 6 of 7
Next